← FDA DRUG APPROVALS

FDA ANDA · ANDA080132

ISONIAZID

Sponsor: PUREPAC PHARM

APPLICATION
ANDA080132
TYPE
ANDA
LATEST ACTION
1985-01-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ISONIAZIDDiscontinued
ISONIAZID 50MG · TABLET · ORAL
ISONIAZIDDiscontinued
ISONIAZID 100MG · TABLET · ORAL

Approval history

1985-01-09Manufacturing (CMC) · Supplement 18AP
1982-07-14Manufacturing (CMC) · Supplement 15AP
1982-03-04Manufacturing (CMC) · Supplement 13AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →